Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:CU6
ASX:CU6Pharmaceuticals

Clarity Pharmaceuticals (ASX:CU6) Is Down 5.2% After PSMA Imaging Trial Hits Primary Endpoint Has The Bull Case Changed?

Clarity Pharmaceuticals recently announced that its Co-PSMA Investigator-Initiated Trial led by St Vincent's Hospital Sydney achieved its primary endpoint, with 64Cu-SAR-bisPSMA detecting a statistically significant higher number of prostate cancer lesions in patients with low PSA compared to the standard-of-care PET/CT imaging. This outcome highlights the potential for 64Cu-SAR-bisPSMA to improve early detection and staging of prostate cancer, addressing a significant clinical need within...
NasdaqCM:GSM
NasdaqCM:GSMMetals and Mining

Ferroglobe (GSM): Assessing Valuation Following Completion of Major Share Buyback

Ferroglobe (GSM) just announced the completion of its latest share repurchase, buying back 13.5 million shares, or 7% of its outstanding stock, since launching the program in May 2024. This move can shift how investors view the company’s value. See our latest analysis for Ferroglobe. Ferroglobe’s momentum has picked up quickly, with a 34% share price return over the past month alone following its aggressive buyback program. While one-year total shareholder return stands at 24%, the company’s...